Trial intelligence / Profile preview

Phase 3 study of edaravone in Japan

jRCT2080224982Phase 3Completed

Start
Dec 2019
Modality
Small Molecules
01

Overview

Phase 3 trial of edaravone. Started Dec 2019; status: completed.

02

Drugs

edaravone

Beyond the preview

Go deeper on jRCT2080224982.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080224982.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call